利塞膦酸抗骨质疏松治疗对骨质疏松大鼠肩袖愈合的影响
本研究在去卵巢骨质疏松大鼠慢性肩袖撕裂修复模型中,探讨利塞膦酸对腱骨愈合的作用。结果显示骨质疏松组早期修复界面破骨细胞密度最高,利塞膦酸可显著降低破骨细胞密度并改善组织学、骨形态计量学和生物力学性能,但效果仍不及非骨质疏松组。
要点
- 骨质疏松通过早期修复界面高破骨细胞活性损害肩袖愈合。
- 术后利塞膦酸降低破骨细胞密度,改善骨质疏松大鼠肩袖愈合。
- 利塞膦酸治疗效果仍低于非骨质疏松对照,需临床验证。
核心结论
- 骨质疏松损害肩袖愈合,可能与早期修复界面高破骨细胞密度相关。
- 术后利塞膦酸降低破骨细胞密度并增强骨质疏松大鼠肩袖愈合,但效果不及非骨质疏松大鼠。
研究设计与样本
- 控制性实验室研究,共84只雌性Sprague Dawley大鼠随机接受去卵巢或假手术建立骨质疏松与非骨质疏松模型。
- 确认骨质疏松后建立慢性肩袖撕裂模型并修复,骨质疏松鼠随机分为OP组和OP+RIS组,非骨质疏松鼠为CON组。
主要发现
- 修复后1和3周,OP组修复界面破骨细胞密度最高。
- 与OP组相比,OP+RIS组破骨细胞密度显著降低。
- 8周时OP+RIS组组织学评分高于OP组但低于CON组,且8周组织学评分与早期破骨细胞密度负相关。
- OP+RIS组骨形态计量参数和生物力学性能优于OP组。
关键数值与推荐
- 骨破骨细胞活性在修复后1和3周测量,组织学分析、骨形态计量评估和生物力学测试在4和8周进行。
临床怎么用
- 术后利塞膦酸给药可考虑作为增强绝经后骨质疏松患者肩袖愈合的潜在治疗,但需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteoporosis increases the revision rate of rotator cuff repair (RCR). Weak fixation might not be the only cause of high RCR failure rates. The biological mechanism associated with tendon-to-bone healing after RCR in osteoporosis should be investigated. HYPOTHESIS: (1) Osteoporosis would impair rotator cuff healing through the high osteoclastic activity at the repaired interface. (2) Risedronate would promote rotator cuff healing by reducing osteoclastic activity at the repaired interface. STUDY DESIGN: Controlled laboratory study. METHODS: A total of 84 female Sprague Dawley rats were randomly treated using ovariectomy or sham surgeries to establish osteoporotic and nonosteoporotic rat models. After confirming osteoporosis, a chronic rotator cuff tear model was created and RCR was performed. Postoperatively, osteoporotic rats were randomly divided into osteoporosis (OP) and osteoporosis with risedronate administration (OP+RIS) groups. Nonosteoporotic rats were used as the control (CON) group. Osteoclastic activity was measured at 1 and 3 weeks after RCR, and histologic analysis of the tendon-to-bone interface, bone morphometric evaluation, and biomechanical tests were performed at 4 and 8 weeks. RESULTS: At the early healing stages of 1 and 3 weeks after RCR, the OP group showed the highest osteoclast density at the repaired interface. Compared with the OP group, risedronate administration significantly decreased osteoclast density in the OP+RIS group. At 8 weeks, histologic scores were greater in the OP+RIS group than in the OP group but still lower than in the CON group. Histologic scores at 8 weeks were negatively correlated with osteoclast density at the early healing stage. Additionally, the OP+RIS group showed better bone morphometric parameters and biomechanical properties than did the OP group. CONCLUSION: Osteoporosis impaired rotator cuff healing, which might be related to the high osteoclast density at the repaired interface at the early healing stage. Postoperative risedronate administration decreased osteoclast density and enhanced rotator cuff healing in osteoporotic rats, although the effect was inferior to that in nonosteoporotic rats. CLINICAL RELEVANCE: Postoperative risedronate administration can be considered a potential therapy to enhance rotator cuff healing in patients with postmenopausal osteoporosis. However, this needs to be verified in a clinical setting.
引用
- Xu J, Su W, Chen J, et al. The Effect of Antiosteoporosis Therapy With Risedronate on Rotator Cuff Healing in an Osteoporotic Rat Model. Am J Sports Med. 2021. PMID: 33998839. doi:10.1177/03635465211011748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。